Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/22/24 16:20 | 10/18/24 | JANX | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | 2 | P.d | 59,868 | 35.32 | 0 | 1,695 | 20 | 10,366 | I | |||||||||||||||
11/15/23 16:48 | 11/13/23 | JANX | Health | Drug | Pharmaceutical Preparations | Reardon Tighe | CA | OT | Acting C | 1 | P | 4,989 | 5.87 | 0 | 850 | 19 | 5,329 | I | ||||||||||||||
11/15/23 16:46 | 11/13/23 | JANX | Health | Drug | Pharmaceutical Preparations | Lichter Jay | CA | DT | 1 | P | 4,989 | 5.87 | 0 | 850 | 10 | 9,717 | I | |||||||||||||||
11/13/23 19:11 | 11/13/23 | JANX | Health | Drug | Pharmaceutical Preparations | Avalon Ventures Xi, L.P. | CA | T | 1 | P | 4,989 | 5.87 | 0 | 850 | 10 | 9,717 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |